REVELATION BIOSCIENCES, INC. Equity Method Investment, Ownership Percentage
REVELATION BIOSCIENCES, INC. (REVB) had Equity Method Investment, Ownership Percentage of 14.00% as of 2021-12-31, per its 10-K filed 2022-04-15.
Discontinued › Notes
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2022-04-15
- 2021-12-31: Equity Method Investment, Ownership Percentage 14.00%.
- 2021-09-30: Equity Method Investment, Ownership Percentage 14.00%.
- 2021-06-30: Equity Method Investment, Ownership Percentage 60.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2021-12-31 | 14.00% 10-K · filed 2022-04-15 |
| 2021-09-30 | 14.00% 10-Q · filed 2021-10-29 |
| 2021-06-30 | 60.00% 10-Q · filed 2021-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |